• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Gene expression-based molecular scoring of pancreas transplant rejection for a quantitative assessment of rejection severity and resistance to treatment.基于基因表达的胰腺移植排斥分子评分,用于定量评估排斥反应的严重程度和对治疗的抵抗性。
Am J Transplant. 2025 Feb;25(2):316-328. doi: 10.1016/j.ajt.2024.09.032. Epub 2024 Sep 28.
2
Use of the Tissue Common Rejection Module Score in Kidney Transplant as an Objective Measure of Allograft Inflammation.组织共同排斥反应模块评分在肾移植中作为同种异体移植物炎症客观指标的应用。
Front Immunol. 2021 Feb 3;11:614343. doi: 10.3389/fimmu.2020.614343. eCollection 2020.
3
A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.外周血基因表达谱诊断亚临床急性排斥反应。
J Am Soc Nephrol. 2019 Aug;30(8):1481-1494. doi: 10.1681/ASN.2018111098. Epub 2019 Jul 5.
4
Acute cellular and antibody-mediated rejection of the pancreas allograft: incidence, risk factors and outcomes.胰腺移植的急性细胞和抗体介导排斥反应:发生率、危险因素和结局。
Am J Transplant. 2013 Nov;13(11):2945-55. doi: 10.1111/ajt.12443. Epub 2013 Sep 19.
5
Diagnostic value of serum miR-144-3p for the detection of acute cellular rejection in heart transplant patients.血清 miR-144-3p 对心脏移植患者急性细胞排斥反应的诊断价值。
J Heart Lung Transplant. 2022 Feb;41(2):137-147. doi: 10.1016/j.healun.2021.10.004. Epub 2021 Oct 22.
6
Transcript analysis of uterus transplant cervical biopsies using the Banff Human Organ Transplant panel.使用班夫人体器官移植标准对子宫移植宫颈活检进行转录分析。
Am J Transplant. 2025 Feb;25(2):329-342. doi: 10.1016/j.ajt.2024.08.027. Epub 2024 Aug 30.
7
Graft dysfunction in simultaneous pancreas kidney transplantation (SPK): Results of concurrent kidney and pancreas allograft biopsies.胰腺肾联合移植(SPK)中的移植物功能障碍:同时进行的肾和胰腺移植活检结果。
Am J Transplant. 2019 Feb;19(2):466-474. doi: 10.1111/ajt.15012. Epub 2018 Aug 13.
8
Clinical Utility of Donor-Derived Cell-Free DNA in Heart Transplant Recipients With Multi-Organ Transplants.多器官移植的心脏移植受者供体来源无细胞 DNA 的临床应用。
Clin Transplant. 2024 Oct;38(10):e15479. doi: 10.1111/ctr.15479.
9
Subclinical Pancreas Rejection on Protocol Biopsy Within the First Year of Simultaneous Pancreas Kidney Transplant.临床下胰腺排斥反应在同时胰腺肾移植后第一年的方案活检中。
Clin Transplant. 2024 Oct;38(10):e15467. doi: 10.1111/ctr.15467.
10
How Should Pancreas Transplant Rejection Be Treated?胰腺移植排斥反应应如何治疗?
Transplantation. 2019 Sep;103(9):1928-1934. doi: 10.1097/TP.0000000000002694.

引用本文的文献

1
Genomics in Pancreas-Kidney Transplantation: From Risk Stratification to Personalized Medicine.胰腺-肾脏移植中的基因组学:从风险分层到个性化医疗
Genes (Basel). 2025 Jul 26;16(8):884. doi: 10.3390/genes16080884.
2
Banff 2022 pancreas pathology update: how to make the right diagnosis and decrease inconclusive pathology results.《2022年班夫胰腺病理学更新:如何做出正确诊断并减少不确定的病理结果》
Curr Opin Organ Transplant. 2025 Aug 1;30(4):258-265. doi: 10.1097/MOT.0000000000001231. Epub 2025 May 21.

本文引用的文献

1
Banff 2022 pancreas transplantation multidisciplinary report: Refinement of guidelines for T cell-mediated rejection, antibody-mediated rejection and islet pathology. Assessment of duodenal cuff biopsies and noninvasive diagnostic methods.班夫 2022 年胰腺移植多学科报告:T 细胞介导排斥反应、抗体介导排斥反应和胰岛病理学指南的细化。评估十二指肠套环活检和非侵入性诊断方法。
Am J Transplant. 2024 Mar;24(3):362-379. doi: 10.1016/j.ajt.2023.10.011. Epub 2023 Oct 21.
2
The Presence of Donor-specific Antibodies Around the Time of Pancreas Graft Biopsy With Rejection Is Associated With an Increased Risk of Graft Failure.胰腺移植活检时出现与排斥反应相关的供体特异性抗体与移植失败风险增加有关。
Transplantation. 2022 Jun 1;106(6):e289-e296. doi: 10.1097/TP.0000000000004133. Epub 2022 Apr 14.
3
OPTN/SRTR 2020 Annual Data Report: Pancreas.器官获取与移植网络/器官共享联合网络2020年度数据报告:胰腺
Am J Transplant. 2022 Mar;22 Suppl 2:137-203. doi: 10.1111/ajt.16979.
4
Use of the Tissue Common Rejection Module Score in Kidney Transplant as an Objective Measure of Allograft Inflammation.组织共同排斥反应模块评分在肾移植中作为同种异体移植物炎症客观指标的应用。
Front Immunol. 2021 Feb 3;11:614343. doi: 10.3389/fimmu.2020.614343. eCollection 2020.
5
Assessment of 19 Genes and Validation of CRM Gene Panel for Quantitative Transcriptional Analysis of Molecular Rejection and Inflammation in Archival Kidney Transplant Biopsies.评估19个基因并验证CRM基因panel用于存档肾移植活检中分子排斥和炎症的定量转录分析
Front Med (Lausanne). 2019 Oct 1;6:213. doi: 10.3389/fmed.2019.00213. eCollection 2019.
6
A urinary Common Rejection Module (uCRM) score for non-invasive kidney transplant monitoring.用于非侵入性肾移植监测的尿通用排斥模块 (uCRM) 评分。
PLoS One. 2019 Jul 31;14(7):e0220052. doi: 10.1371/journal.pone.0220052. eCollection 2019.
7
How Should Pancreas Transplant Rejection Be Treated?胰腺移植排斥反应应如何治疗?
Transplantation. 2019 Sep;103(9):1928-1934. doi: 10.1097/TP.0000000000002694.
8
The common rejection module in chronic rejection post lung transplantation.慢性移植肺排斥反应中的常见排斥模块。
PLoS One. 2018 Oct 5;13(10):e0205107. doi: 10.1371/journal.pone.0205107. eCollection 2018.
9
Targeted Transcriptional Profiling of Kidney Transplant Biopsies.肾移植活检的靶向转录谱分析
Kidney Int Rep. 2018 Feb 3;3(3):722-731. doi: 10.1016/j.ekir.2018.01.014. eCollection 2018 May.
10
Advances in diagnostics for transplant rejection.移植排斥反应诊断技术的进展。
Expert Rev Mol Diagn. 2016 Oct;16(10):1121-1132. doi: 10.1080/14737159.2016.1239530.

基于基因表达的胰腺移植排斥分子评分,用于定量评估排斥反应的严重程度和对治疗的抵抗性。

Gene expression-based molecular scoring of pancreas transplant rejection for a quantitative assessment of rejection severity and resistance to treatment.

作者信息

Brown Audrey E, Kelly Yvonne M, Zarinsefat Arya, Meier Raphael P H, Worner Giulia, Tavakol Mehdi, Sarwal Minnie M, Laszik Zoltan G, Stock Peter G, Sigdel Tara K

机构信息

Department of Surgery, University of California, San Francisco, California, USA.

Department of Surgery, University of California, San Francisco, California, USA; Department of Surgery, Columbia University, New York, New York, USA.

出版信息

Am J Transplant. 2025 Feb;25(2):316-328. doi: 10.1016/j.ajt.2024.09.032. Epub 2024 Sep 28.

DOI:10.1016/j.ajt.2024.09.032
PMID:39349170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11878653/
Abstract

Pancreas transplantation improves glycemic control and mortality in patients with diabetes but requires aggressive immunosuppression to control the alloimmune and autoimmune response. Recent developments in "omics" methods have provided gene transcript-based biomarkers for organ transplant rejection. The tissue Common Response Module (tCRM) score is developed to identify the severity of rejection in kidney, heart, liver, and lung transplants. Still, it has not yet been validated in pancreas transplants (PT). We evaluated the tCRM score's relevance in PT and additional markers of acute cellular rejection (ACR) for PT. An analysis of 51 pancreas biopsies with ACR identified 37 genes and 56 genes significantly upregulated in the case of grade 3 and grade 2 ACR, respectively (P < .05). Significant differences were seen with higher grades of rejection among several transcripts. Of the 22 genes differentially expressed in grade 3 ACR, 18 were also differentially expressed in grade 2 ACR. The rejection signal was attributable to activated leukocytes' infiltration. Significantly higher tCRM scores were found in grade 3 ACR (P = .007) and grade 2 ACR (P = .004), compared to normal samples. The tCRM score was able to distinguish treatment-resistant cases from those successfully treated for rejection.

摘要

胰腺移植可改善糖尿病患者的血糖控制并降低死亡率,但需要积极的免疫抑制来控制同种免疫和自身免疫反应。“组学”方法的最新进展为器官移植排斥反应提供了基于基因转录本的生物标志物。组织共同反应模块(tCRM)评分用于识别肾、心、肝和肺移植排斥反应的严重程度。然而,它尚未在胰腺移植(PT)中得到验证。我们评估了tCRM评分在PT中的相关性以及PT急性细胞排斥反应(ACR)的其他标志物。对51例发生ACR的胰腺活检组织进行分析,结果显示,在3级和2级ACR病例中,分别有37个基因和56个基因显著上调(P <.05)。在几个转录本中,较高等级的排斥反应存在显著差异。在3级ACR中差异表达的22个基因中,有18个在2级ACR中也有差异表达。排斥信号归因于活化白细胞的浸润。与正常样本相比,3级ACR(P =.007)和2级ACR(P =.004)的tCRM评分显著更高。tCRM评分能够区分抗治疗的病例和成功治疗排斥反应的病例。